CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine

BACKGROUND: There is limited evidence on interventions to minimise weight gain at clozapine commencement. We compared the effect of adjunctive metformin versus placebo at clozapine initiation. METHODS: People with schizophrenia commencing on clozapine were randomised to either metformin or placebo f...

Descripción completa

Detalles Bibliográficos
Autores principales: Siskind, Dan, Russell, Anthony W., Suetani, Shuichi, Flaws, Dylan, Kisely, Steve, Moudgil, Vikas, Northwood, Korinne, Robinson, Gail, Scott, James G., Stedman, Terry, Warren, Nicola, Winckel, Karl, Cosgrove, Peter, Baker, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521414/
https://www.ncbi.nlm.nih.gov/pubmed/34671454
http://dx.doi.org/10.1177/20451253211045248

Ejemplares similares

Ejemplares similares